Arrowhead Pharmaceuticals Aktie
67,78
EUR
-0,32
EUR
-0,47
%
79,66
USD
+1,75
USD
+2,25
%
Werbung
Arrowhead Pharmaceuticals Aktie Analyse
| 07.09.18 | Arrowhead Pharmaceuticals Buy | B. Riley FBR | |
| 06.09.18 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets | |
| 08.08.18 | Arrowhead Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 02.07.18 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets | |
| 09.05.18 | Arrowhead Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 10.11.16 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets | |
| 19.05.16 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets |
Werbung
Werbung